Sutro Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	58.13	190.3	69.27	47.25	30.41
Short-Term Investments	83.3	126.59	306.35	287.11	167.52
Cash & Short-Term Investments	141.43	316.9	375.62	334.36	197.94
Cash Growth	-55.37%	-15.63%	12.34%	68.92%	-46.23%
Accounts Receivable	3.98	8.62	36.08	7.12	12.45
Other Current Assets	5.52	17.8	9.85	11.67	8.12
Total Current Assets	150.93	343.31	421.54	353.15	218.52
Net Property, Plant & Equipment	21.55	35.87	44.76	51.06	51.59
Long-Term Investments	-	-	-	-	68.78
Other Long-Term Assets	1.35	8.03	4.44	2.73	2.53
Total Assets	173.83	387.21	470.74	406.94	341.41
Accounts Payable	7.57	10.48	9.44	4.8	6.01
Accrued Expenses	49.22	44.16	53.16	27.91	19.82
Current Portion of Long-Term Debt	-	-	4.06	12.5	9.38
Current Portion of Leases	7.78	7.48	6.42	4.59	1.04
Unearned Revenue	10.56	69.78	20.67	16.76	5.5
Total Current Liabilities	75.13	131.89	93.75	66.55	41.74
Long-Term Debt	-	-	-	3.77	15.74
Long-Term Leases	7.89	15.67	23.15	29.57	31.22
Other Long-Term Liabilities	223.26	195.04	204.19	90	0.15
Total Long-Term Liabilities	231.15	210.71	227.34	123.35	47.11
Total Liabilities	306.28	342.61	321.09	189.9	88.84
Common Stock	0.01	0.01	0.06	0.06	0.05
Additional Paid-in Capital	845.48	831.42	708.98	670.22	586.24
Accumulated Other Comprehensive Income	0.02	0.04	0.02	-0.62	-0.31
Retained Earnings	-977.96	-786.87	-559.41	-452.62	-333.41
Shareholders' Equity	-132.45	44.6	149.65	217.05	252.56
Total Liabilities & Equity	173.83	387.21	470.74	406.94	341.41
Total Debt	15.67	23.15	33.64	50.43	57.37
Net Cash (Debt)	125.75	293.74	341.98	283.93	140.56
Net Cash Growth	-57.19%	-14.11%	20.45%	102.00%	-59.09%
Net Cash Per Share	14.80	37.97	56.84	55.96	30.48
Book Value	-132.45	44.6	149.65	217.05	252.56
Book Value Per Share	-15.59	5.76	24.87	42.78	54.76
Tangible Book Value	-132.45	44.6	149.65	217.05	252.56
Tangible Book Value Per Share	-15.59	5.76	24.87	42.78	54.76

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q